The BPV1-E2 trans-acting protein can be either an activator or a repressor of the HPV18 regulatory region
- PMID: 2828029
- PMCID: PMC553796
- DOI: 10.1002/j.1460-2075.1987.tb02662.x
The BPV1-E2 trans-acting protein can be either an activator or a repressor of the HPV18 regulatory region
Abstract
The human papillomavirus 18 (HPV 18) long control region contains promoter and enhancer elements whose activity is restricted to several human cell lines of epithelial origin. This enhancer possesses a considerable constitutive activity which is further stimulated in the presence of the E2 trans-activating protein of bovine papillomavirus 1 (BPV1). Surprisingly the same BPV1 protein strongly repressed transcription from the genuine HPV18 enhancer-promoter DNA sequences. We suggest that binding of several molecules of E2 protein between the viral CAAT and TATA elements sterically hinders transcription initiation from this promoter, while the same DNA--protein assembly stimulates the SV40 promoter when cloned in an enhancer configuration upstream of this heterologous promoter. Unlike BPV1-E2 the homologous E2 gene product does not seem to strongly modulate viral transcription. Finally the BPV1-E2 gene product may repress some essential viral or host genes, since we failed to isolate HeLa cells expressing BPV1-E2.
Similar articles
-
The human papillomavirus type 18 (HPV18) E2 gene product is a repressor of the HPV18 regulatory region in human keratinocytes.J Virol. 1989 Oct;63(10):4317-24. doi: 10.1128/JVI.63.10.4317-4324.1989. J Virol. 1989. PMID: 2476572 Free PMC article.
-
Regulation of human papillomavirus type 11 enhancer and E6 promoter by activating and repressing proteins from the E2 open reading frame: functional and biochemical studies.J Virol. 1988 Aug;62(8):2994-3002. doi: 10.1128/JVI.62.8.2994-3002.1988. J Virol. 1988. PMID: 2839716 Free PMC article.
-
Enhancers and trans-acting E2 transcriptional factors of papillomaviruses.J Virol. 1987 Aug;61(8):2599-606. doi: 10.1128/JVI.61.8.2599-2606.1987. J Virol. 1987. PMID: 3037119 Free PMC article.
-
Trans-activation of an upstream early gene promoter of bovine papilloma virus-1 by a product of the viral E2 gene.EMBO J. 1987 Jan;6(1):145-52. doi: 10.1002/j.1460-2075.1987.tb04732.x. EMBO J. 1987. PMID: 3034572 Free PMC article.
-
Functional analysis of E2-mediated repression of the HPV18 P105 promoter.New Biol. 1991 Jan;3(1):90-100. New Biol. 1991. PMID: 1645591
Cited by
-
Interaction of the bovine papillomavirus type 1 E2 transcriptional control protein with the viral enhancer: purification of the DNA-binding domain and analysis of its contact points with DNA.J Virol. 1988 Jun;62(6):1925-31. doi: 10.1128/JVI.62.6.1925-1931.1988. J Virol. 1988. PMID: 2835497 Free PMC article.
-
Mechanisms of human papillomavirus E2-mediated repression of viral oncogene expression and cervical cancer cell growth inhibition.J Virol. 2000 Apr;74(8):3752-60. doi: 10.1128/jvi.74.8.3752-3760.2000. J Virol. 2000. PMID: 10729150 Free PMC article.
-
Brd4 is displaced from HPV replication factories as they expand and amplify viral DNA.PLoS Pathog. 2013;9(11):e1003777. doi: 10.1371/journal.ppat.1003777. Epub 2013 Nov 21. PLoS Pathog. 2013. PMID: 24278023 Free PMC article.
-
High-Risk Human Papillomaviral Oncogenes E6 and E7 Target Key Cellular Pathways to Achieve Oncogenesis.Int J Mol Sci. 2018 Jun 8;19(6):1706. doi: 10.3390/ijms19061706. Int J Mol Sci. 2018. PMID: 29890655 Free PMC article. Review.
-
Numerous nuclear proteins bind the long control region of human papillomavirus type 16: a subset of 6 of 23 DNase I-protected segments coincides with the location of the cell-type-specific enhancer.J Virol. 1989 Mar;63(3):1142-52. doi: 10.1128/JVI.63.3.1142-1152.1989. J Virol. 1989. PMID: 2536825 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical